National Bankshares Has Lowered Expectations for TELUS (TSE:T) Stock Price
4 Articles
4 Articles
Bank of America Cuts Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $58.00
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) had its price target dropped by equities research analysts at Bank of America from $72.00 to $58.00 in a report released on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Bank of America‘s price objective indicates a potential upside of 151.68% from […]
Jefferies Financial Group Has Lowered Expectations for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) had its target price dropped by Jefferies Financial Group from $114.00 to $63.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Jefferies Financial Group’s target price would indicate a potential upside of 173.91% from the […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
